Abstract
Common practice is to withhold vaccination with live-attenuated vaccines in patients with rheumatic diseases on high-dose DMARDs, glucocorticosteroids or biological agents, due to limited safety data, and the risk of introducing an infectious disease to the patient. Evidence for this approach is low. We collected data from pediatric rheumatologists who regularly have vaccinated these patients, to obtain additional safety data, which might update and revise such approach. Data from 13 pediatric rheumatology centers in 10 countries were collected and herein discussed.
Lingua originale | English |
---|---|
pagine (da-a) | 178-179 |
Numero di pagine | 2 |
Rivista | Annals of the Rheumatic Diseases |
DOI | |
Stato di pubblicazione | Pubblicato - 2019 |
Evento | EULAR European Congress of Rheumatology - MADRID Durata: 12 giu 2019 → 15 giu 2019 |
Keywords
- Vaccinations